Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, Sep 1996, 1983-1987, Vol 40, No. 9
YQ Zhu, KM Remington and TW North
We selected mutants of feline immunodeficiency virus (FIV) that are
resistant to 2',3'-dideoxy-2',3'-didehydrothymidine (d4T). Two mutants were
selected in cultured cells with a stepwise increase in d4T concentration,
resulting in mutants able to replicate in 100 microM d4T. These mutants
were three- to sixfold more resistant to d4T than wild-type FIV. They were
also cross-resistant to 3'-azido-3'- deoxythymidine (AZT),
3'-fluoro-2',3'-dideoxythymidine, 2',3'- dideoxycytidine,
2',3'-dideoxyinosine, and 9-(2- phosphonylmethoxyethyl)adenine, and they
were highly resistant to phosphonoformic acid (PFA). Plaque-purified
mutants were isolated from each of the mutant populations. The mutant
phenotype was stable, because both of the plaque-purified mutants remained
d4T resistant even after three passages in the absence of d4T. One of the
plaque-purified mutants, designated D4R-3c, was further characterized.
Compared with wild-type reverse transcriptase (RT), RT purified from D4R-3c
was 3- fold resistant to inhibition by the 5'-triphosphate of d4T, 10-fold
resistant to inhibition by the 5'-triphosphate of AZT, and 6-fold resistant
to PFA. D4R-3c had a single point mutation in the RT-encoding region of the
pol gene at position 2474, resulting in a Val to Ile mutation at codon 47
of the FIV RT. The role of this mutation in d4T resistance was confirmed by
site-directed mutagenesis.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Mutants of feline immunodeficiency virus resistant to 2',3'-dideoxy- 2',3'-didehydrothymidine
Division of Biological Sciences, University of Montana, Missoula 59812, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»